Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000214 · ClinicalTrials.gov registry record · Phase 2
IV Cocaine Abuse: A Laboratory Model - 3
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000214 is a Phase 2 study that has completed, run by New York State Psychiatric Institute.
The verdict
NCT00000214, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-01 |
| Est. Completion | 1993-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000214
The ClinicalTrials.gov registry entry for NCT00000214 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000214 about?
NCT00000214 is a clinical study titled "IV Cocaine Abuse: A Laboratory Model - 3". The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
What is the current status of trial NCT00000214?
This trial is currently completed. It is a Phase 2 study. The study started on 1992-01. Estimated completion is 1993-01.
What interventions are being tested in trial NCT00000214?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000214?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.